Risks of Antibiotics in Animal Waste Christopher Ohl MD, FACP Associate Professor of Medicine Section on Infectious Diseases Wake Forest University School.

Slides:



Advertisements
Similar presentations
Antibiotic Stewardship Curriculum Developed by: Vera P. Luther, M.D.
Advertisements

2011 National Environmental Health Association Meeting Crispin Pierce, Sasha Showsh, and Eli Gottfried (faculty) Tola Ekunsanmi, Michael Checkai, Jay Nielsen,
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
Quantity of Antimicrobials Used in Food Animals in the United States Charles M. Benbrook Consultant to the Union of Concerned Scientists 101st Annual Meeting.
What intervention on the use or dosing of antibiotics work to decrease resistance? Jan. 18, 2007 Sung-Ching Pan.
Copyright © Medical Technology Department Vancomycin Resistant Enterococci (VRE) among Non–Hospitalized Individuals in Gaza City, Palestine Rasha R. Rashed.
Should we change the recommendations related to antibiotic drug dosage/drug duration? Workshop on Economic Epidemiology Makerere University August, 2009.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
APPENDIX. 2 Objective Status: Food Safety FS-1.1 Reduce infections caused by Campylobacter species transmitted commonly through food FS-1.2 Reduce infections.
Antibiotic Resistant Bacteria Emerging From the Agricultural Industry Stormy R. Thomas and Paul-Michael Gallagher Department of Biological Sciences, College.
Use of antibiotics. Antibiotic use Antimicrobials are the 2 nd most common drugs prescribed by office based physicians In USA1992: 110 million oral antimicrobial.
ANTIMICROBIAL RESISTANCE Edith Blondel-Hill MD,FRCP Medical Microbiologist/Infectious Diseases Specialist Medical Director Interior Health Antimicrobial.
Antimicrobial Stewardship Program JMH House staff Orientation 2012 Lilian Abbo, MD Assistant Professor Clinical Infectious Diseases Laura Smith, PharmD.
Food Safety and Inspection Service U. S. Department of Agriculture
Multidrug resistant organisms: What are we up against? Hans Jørn Kolmos MD DMSc Professor, consultant Department of Clinical Microbiology Odense University.
CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE Dr. Jolanta Miciulevičienė Vilnius City Clinical Hospital National Public Health.
NOSOCOMIAL INFECTIONS Phase 1: Testing the efficacy of Nano-Mg (OH) 2 Dorothea A. Dillman PhD, RN, CCRN, LNC.
Antibiotics Peter Davies BVSc, PhD College of Veterinary Medicine University of Minnesota Beliefs Opinions Evidence Actions Outcomes Expectations.
1 December 2014 Working across sectors: a public health approach to to antimicrobial resistance.
CSI 101 Skills Lab 2 Standard Precautions Personal Protective Equipment (PPE) Daryl P. Lofaso, M.Ed, RRT.
Are we entering a post-antibiotic era?
IDSA / ISAP / FDA Workshop on Antimicrobial Drug Development Update 2004 Edward Cox, MD MPH ODE IV Center for Drug Evaluation and Research US Food and.
Nosocomial infection Hospital Infection. Hospital acquired infections Nosocomial infections are those that originate or occur in a hospital or hospital-like.
Antimicrobial Resistance - Reducing the Over-Use of Antibiotics. Institute of Food Science and Technology, Spring Conference; 18/04/2013 Jeff Jones, Animal.
“Emerging infections, the re-emergence of infectious diseases previously considered to be under control, and the alarming trend of antibiotic resistance….require.
Ranking of Antimicrobial Drugs According to Importance in Human Medicine John H. Powers, M.D. Lead Medical Officer Antimicrobial Drug Development and Resistance.
The Antibiotic Sensitivity Test Presented by Marian Mikhail Undergraduate student Biology Major Health and Science Concentration Health and Science Concentration.
Shira Doron, MD Assistant Professor of Medicine
DR.M.F MOUSSA B.Sc,M.B.B.S Diplomé en Santé Publique Victoria Hospital,Candos.
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
E. coli O157:H7 -- Illness trends and recent data from outbreak investigations, United States Shiga Toxin –Producing E. coli Addressing the Challenges,
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
Increased resistance due to ”non-human” antibiotic use (veterinary and zootechnical use) Christina Greko Dept of Antibiotics National Veterinary Institute.
WISCONSIN STATE LABORATORY OF HYGIENE 1 Analysis and Comparison of Cumulative Statewide Antibiograms for Wisconsin, 2006 and 2008 Christina M. Carlson.
Pathogen Reduction Dialogue Panel 2 HACCP Impacts on Contamination Levels in Meat and Poultry Products: FSIS Perspective Delila R. Parham, DVM Office of.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Antimicrobial Resistance in Streptococcus pneumoniae Implications for Prescription Drug Labeling John H. Powers, MD Lead Medical Officer Antimicrobial.
Antimicrobial Drugs  Chemotherapy: the use of drugs to treat a disease  Antimicrobial drugs: interfere with the growth of microbes within a host  Antibiotic:
DENS 521 Clinical Dental Therapeutics 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
Concentrated Animal Feeding Operations Global Warming and Air Pollution.
Supplemental testing methods
Center for Drug Evaluation and Research March 6, 2005 Bacteremia and Endocarditis: Products and Guidance Janice Soreth, MD Director Division of Anti-Infective.
Development of Drugs for Resistant Pathogens Francis P. Tally M.D. Cubist Pharmaceuticals, Inc.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Ranking of Antimicrobial Drugs Relative to Their Use in Animals Richard Carnevale VMD Vice President, Scientific, Regulatory and International Affairs.
Pathogen Reduction Dialogue Panel 1 Introduction of Hazards, Farm to Table May 6, 2002 Introduction Chair: Michael Doyle, PhD Regents Professor of Food.
Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern Qualitative Antimicrobial.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Why how we raise our food matters.  QUIZ!!  Take out the CQ Researcher Reading and a pen/pencil  Everything else needs to be put away!
Using AMR surveillance for developing policy AMR meeting Washington 13 April 2016.
Tigecycline use in serious nosocomial infections: a drug use evaluation Matteo Bassetti*, Laura Nicolini, Ernestina Repetto, Elda Righi, Valerio Del Bono,
Phage therapy for the treatment for urinary tract infection: Results of in-vitro screenings and in-vivo application using commercially available bacteriophage.
Jean B. Patel, PhD, D(ABMM) Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Disease Centers for Disease Control.
Materials & Methods Objective Extraintestinal pathogenic Escherichia coli in healthy broiler chicken in Italy: a combination of virulence with antibiotic.
HAP and VAP Guidelines Update
Veterinary Antimicrobial Use Regulations
Antibiotic Resistance
Dr.Mowna Karthick M.D MICROBIOLOGY
The following are slide excerpts from a presentation to a state hospital association CEO committee by a hospital food service director.
REDUCED RATES OF VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) COLONIZATION
Salmonella Risk in Poultry Meat
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
CSI 101 Skills Lab 3 Universal Precautions and
Medical Microbiology Chapter 24 Enterococcus.
Neonatal sepsis in Kilifi
Regulating Antibiotics in Animal Feed
Presentation transcript:

Risks of Antibiotics in Animal Waste Christopher Ohl MD, FACP Associate Professor of Medicine Section on Infectious Diseases Wake Forest University School of Medicine Winston-Salem, NC

Objectives Overview of antimicrobial resistance Discuss the 3 origins of antibiotic resistant infections in humans Discuss antimicrobial use in humans and animals Present risk to humans from antimicrobial use and resistance in food animals and their environment Briefly present governmental and regulatory response to the problem

Antibiotics Have Transformed Human Medicine

Antimicrobial Targets Only 1 New Antibiotic With a Novel Target in Last 20 Years

Antimicrobial resistant Nosocomial Infections In ICU Patients 1999 compared with , NNIS OrganismIncrease in resistance VRE43% MRSA37% MRSE2% 3 rd Ceph E. coli8% 3 rd Ceph K. pneumoniae-3% Imipenem P. aeruginosa56% Quinolone P. aeruginosa50% 3 rd Ceph P. aeruginosa10% 3 rd Ceph Enterobacter sp.-4%

Campylobacter jejuni & C. coli Quinolone Resistance Engberg et al Emerg Infect Dis 7:24

Doern GV. Am J Med. 1995;99: 3S-7S. Jacobs MR, et al. AAC. 1999:43:1901. Jacobs MR, et al. ICAAC. 1999; Abstract C-61. Penicillin-Resistant S. pneumoniae United States ( ) Year Penicillin Resistant, % Intermediate (0.12 to 1.0 µg/ml) Resistant (>2.0 µg/ml) % 16% 18% 33%

Morbidity and mortality of infections greater for resistant compared with susceptible organisms New drugs designed to combat bacterial resistance are becoming scarce and more costly Cost of antibiotic resistance in the U.S. estimated in 1996 at $30 billion IMPACT

Cycle of Antibiotic Resistance Acquisition Under Increasing Antibiotic Selection Pressure

The Farm The Hospital The Clinic Origins of Human Antimicrobial Resistance

The Farm The Hospital The Clinic Origins of Human Antimicrobial Resistance

Adult Antibiotic Prescriptions by Diagnosis Diagnosis Bronchitis Sinusitis Other respiratory Otitis media Skin Pneumonia Wounds All others % Rxs Physician Drug and Diagnosis Audit (PDDA) 1997, Scott-Levin.

The Farm The Hospital The Clinic Origins of Human Antimicrobial Resistance

Percent of Cattle that Received the Following Antimicrobials in Feed or Water Feedlot 1999 – Part III, USDA/NAHMS survey, December 2000

Percent of Sites that Gave Antibiotics to Weaned Pigs as a Preventative Practice USDA/APHIS Veterinary Services Info Sheet, March 2002

Most Common Antibiotics (by route) Grower/Finisher Pigs USDA/APHIS Veterinary Services Info Sheet, March 2002 Percent of Farm Sites

Antimicrobials in Feed to Grower/Finisher for any Reason Swine 2000 – Part II, USDA/NAHMS survey, August 2001

Antimicrobials in Feed to Poultry Nontherapeutic, 1998 Mellon, et al. Union of Concerned Scientists, 2001

Antibiotic Use in US: Animals vs Humans Current estimated use/year –Animals: 26.6 million lbs –Humans: 3 million lbs Mellon, et al. Union of Concerned Scientists, 2001 Reasonable estimate ~50% of all antimicrobials in North America are given to animals Gorbach NEJM. 345:1202 Classes shared: penicillin, cephalosporin (all generations), macrolides, sulfas, macrolide/lincosamide/streptogramin, aminoglycoside, quinolone

Antibiotic Use in US: Animals vs Humans Compare and Contrast AnimalsHumans Individual TreatmentYes, by vet or caretaker Yes, by MD Mass TreatmentYes, oftenVery rare Preventive TreatmentOftenSeldom “Growth Promotion”YesNo Duration / doseLong / lowShort / high

Is Antibiotic Use on the Farm Related to Antibiotic Resistance? On the Farm: Yes –Controlled challenge studies –Farm animal microbiologic surveys –Farm environmental microbiologic surveys –Abattoir investigations –Retail meat Pathogens of human interest –Campylobacter sp. (Resis. to FQ’s, macrolides) –Salmonella typhimurium, S. newport; (multidrug resistant common, FQ Resis. rare in US) –Enterococcus sp. (R Streptogramins, tetracyclines, vancomycin, macrolides) –E. coli (tetracyclines, cephalosporins, aminoglycosides, trimethoprim-sulfamethoxazole, FQs) APUA/FAAIR: Clin Inf Dis. 34: supplement 3 GAO. RCED FDA. WHO.

Is Antibiotic Use on the Farm Related to Antibiotic Resistance in Humans? Colonized Animal Susceptible Human Slaughter Retail Meat Occupational Soil Ground water Surface water Air 3 Possible Routes Food borneEnvironmental Van den Bogaard Int J. Antimicrob Agents. 14:327

Quinolone Resistant C. jejuni Minnesota isolates from ill humans 1997: 14% of retail chicken meat with quinolone resistant C. jejuni Human and chicken isolates related molecularly Only 15% of cases could be explained by prior human quinolone use or foreign travel FQ Use in Poultry Smith, et al NEJM 340:1525

Glynn, M. K. et al. N Engl J Med 1998;338: Prevalence of Resistance to Ampicillin, Chloramphenicol, Streptomycin, Sulfonamides, and Tetracycline among Typhimurium Isolates Identified by Surveys of Antimicrobial-Drug Resistance in Sentinel Counties

Enterococcus faecium Streptogramin Resistance Common in chicken retail meat, but rare in humans: microbiologic survey of stools submitted to clinical laboratories show 1% colonized. –McDonald NEJM 345:1155 Challenge study in 6 humans with streptogramin resistant E. faecium spiked chicken or pork – Sorensen NEJM. 345:1161 Recent risk assessment by FDA-CVM –“ assuming a food pathway attribution of 10%, the average risk to a random member of the US population of having SREF attributable to animal uses of virginiamycin and that may result in impaired Synercid therapy ranges from 7 chances in 1 billion to 14 chances in 100 million in one year” –FDA-CVM

Possible Animal Origin of Human- Associated, MDR uropathogenic E. coli Multistate outbreak of TMP-SXT resistant E. coli urinary tract infections PFGE and PCR fingerprinting 1 isolate from a cow was found in a cluster of human isolates Conclusion: origin of this drug resistant strain potentially has an animal origin

Occupational and Farm Resident Risk Tetracycline resistant E. coli transferred to farmers and farm families (31.3% compared with 6.8% of neighbors) –Levy NEJM 295:583 Macrolide resistant S. aureus and Streptococci as well as Enterobacteriaceae resistant to quinolone, TMP-SXT, tetracycline and aminoglycoside more common in pig farmers than controls – Aubry-Damon et al Emerg Infect Dis. 10:873 Enterococci resistant to streptogramins or vancomyin transferred from chicken and turkey flocks to farm workers –Willems et al J. Infect Dis. 182:816 –Van den Boggard et al NEJM. 337:1558 Ceftriaxone resistant S. typhimurium transferred from cattle to 12 y.o. farm resident causing severe intestinal illness. –Fey et al NEJM. 342:1242

1 or more antibiotics found in 48% of streams sampled. 14 of 22 antibiotics detected at least once. Concentrations generally low (<0.5 ppb). Most frequently detected antibiotics: trimethoprim (27.4%), erythromycin-H2O (21.5%), lincomycin (19.2%), sulfamethoxazole (19.0%), tylison (13.5%). Antibiotics found in streams downstream of both intensive urban (68%) and livestock (39%) activity. Antibiotics in Surface Water Kolpin et al. Environ Sci Technol :1202

US Governmental Response

Release Assessment Exposure Assessment Qualitative Risk Assessment Consequence Assessment Risk Estimation Risk estimation integrates results from release, exposure and consequence assessments to produce overall measure of risk associated with hazards _____________________________________________________________________________________________________ Text only version Press Release: Antimicrobial Animal Drugs FDA Home Page FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | AccessibilitySearch FDA Site FDA A-Z Index Contact FDA PrivacyAccessibility Slide 11 of 21 Back to Slide 1Back to Slide 1

Can Risk Be Reversed? Danish Growth Promoter Withdrawal Experience Complete withdrawal of antimicrobials for growth promotion or disease prevention but not therapeutics by end of 1999 Antimicrobial use decreased 54% from 1994 to 2001 Some increase in therapeutic use in pigs but not poultry Dramatically reduced food animal reservoir AR enterococci Possible increase in tetracycline resistance in food animal salmonella No measurable change in food-borne pathogen AR in humans (illness or commensal) Minimal impact on animal welfare Economic impact: Modest decreased feed efficiency in weaners and poultry. GDP 0.03% decrease. (~1 euro/pig) WHO/CDS/CPE/2FK/2003.1

“I say we do it … and trichinosis be damned!”